Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Redekop, W. Ken
281  Ergebnisse:
englisch X
Personensuche X
?
1

Radiology AI Deployment and Assessment Rubric (RADAR) to br..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Bos, Daniel...
Insights into Imaging.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Broadening the HTA of medical AI: A review of the literatur..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Visser, Jacob J...
Health Policy and Technology.  13 (2024)  2 - p. 100868 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Long-Term Effects of Dexmedetomidine versus Propofol During..:

ter Bruggen, Feline FJA ; Redekop, W Ken ; Stronks, Dirk L.
Journal of Pain Research.  14 (2021)  - p. 3631-3636 , 2021
Link: https://doi.org/10.2147/..
 
?
4

A Systematic Review of Cost-Effectiveness Studies of Interv..:

Galekop, Milanne M.J. ; Uyl-de Groot, Carin A. ; Ken Redekop, W.
Value in Health.  24 (2021)  3 - p. 325-335 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Future of Data Analytics in the Era of the General Data Pro..:

Kolasa, Katarzyna ; Ken Redekop, W. ; Berler, Alexander..
PharmacoEconomics.  38 (2020)  10 - p. 1021-1029 , 2020
Link: https://doi.org/10.1007/..
 
?
6

In this issue: improving health outcomes and reducing healt..:

Redekop, W. Ken
Health Policy and Technology.  8 (2019)  3 - p. 207-208 , 2019
Link: https://doi.org/10.1016/..
 
?
7

European cooperation on healthcare: report on the FPM-HPT c..:

Singer, Donald R.J. ; Bakker, Lytske J. ; Redekop, W. Ken
Health Policy and Technology.  8 (2019)  3 - p. 209-210 , 2019
Link: https://doi.org/10.1016/..
 
?
8

How can we make better decisions about the development and ..:

Redekop, W. Ken
Health Policy and Technology.  8 (2019)  1 - p. 3-4 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Author Correction to: Adjuvant Trastuzumab Therapy for Earl..:

Ansaripour, Amir ; Uyl-de Groot, Carin A. ; Redekop, W. Ken
PharmacoEconomics.  36 (2018)  4 - p. 505-505 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Use of data-mining to support real-world cost analyses: An ..:

Ansaripour, Amir ; Zendehdel, Kazem ; Tadayon, Niki...
PLOS ONE.  13 (2018)  10 - p. e0205079 , 2018
Link: https://doi.org/10.1371/..
 
?
11

International differences in patient access to ultra-orphan..:

Kanters, Tim A. ; Redekop, W. Ken ; Hakkaart, Leona
Health Policy and Technology.  7 (2018)  1 - p. 57-64 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Response to 'Comment on ''Adjuvant Trastuzumab Therapy for ..:

Ansaripour, Amir ; Uyl-de Groot, Carin A. ; Redekop, W. Ken
PharmacoEconomics.  36 (2018)  3 - p. 381-382 , 2018
Link: https://doi.org/10.1007/..
 
?
13

Fake news, big data, and the opportunities and threats of t..:

Redekop, W. Ken
Health Policy and Technology.  7 (2018)  2 - p. 113-114 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Healthcare problems cannot be solved using health technolog..:

Redekop, W. Ken ; Bakker, Lytske J. ; Aarts, Jos
Health Policy and Technology.  7 (2018)  1 - p. 3-4 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Cost-effectiveness of enzyme replacement therapy with alglu..:

Kanters, Tim A. ; van der Ploeg, Ans T. ; Kruijshaar, Michelle E....
Orphanet Journal of Rare Diseases.  12 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
1-15